To extend the mouse model to human leukaemia, we first used K562, which is a BCR-ABL positive cell line derived from a CML patient in blast crisis and are resistant to most forms of chemotherapy. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.